Several studies demonstrated the efficacy of ([18F]FES-PET/CT (FES-PET) for imaging evaluation of ER+ invasive BC, with high concordance between ER status determined by immunohistochemical methods and FES-PET results [67]. Here, ESR1 is linked to breast cancer.